Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
000950.SZ
HOLDGet insider-trade alertsC.Q. Pharmaceutical Holding Co., Ltd. · Healthcare · China · $1.3B · Avg Vol: $22M/d
COMPANY DESCRIPTION
C.Q. Pharmaceutical Holding Co., Ltd. engages in pharmaceutical distribution, retail pharmacy operations, and medical logistics services across China. The company commands a dominant market share in Western China, supported by an extensive distribution network and hospital partnerships. It is a leading regional healthcare distributor expanding its national footprint through strategic acquisitions.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 10.0B | 11.5B | 11.9B | 12.1B | 6.7% | 12.1B |
| EPS | 0.08 | 0.05 | 0.02 | 0.03 | -26.3% | 0.04 |
| Shares | 1.7B | 1.7B | 1.7B | 1.7B | -0.9% | 1.7B |
| Debt | 3.3B | 3.0B | 3.5B | 3.4B | 1.4% | 3.7B |
| Equity | 1.6B | 1.7B | 1.7B | 1.7B | 2.7% | — |
| Op CF | 42.1M | 74.9M | -27.5M | 111.1M | 38.2% | -58.5M |
| Inv CF | -28.2M | -52.8M | -26.9M | 24.1M | — | — |
| Fin CF | 173.8M | 37.2M | 7.1M | -140.6M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000950.SZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 000950.SZ | C.Q. Pharmaceutical Holding Co., Ltd.(you) | $1.3B | 51 | HOLD |
| 600739.SS | Liaoning Cheng Da Co., Ltd. | $2.2B | 56 | HOLD |
| 301584.SZ | Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. | $1.2B | 29 | SELL |
| 002589.SZ | Realcan Pharmaceutical Group Co., Ltd. | $543M | 39 | HOLD |
| 600056.SS | China Meheco Group Co., Ltd. | $1.9B | 80 | BUY |
| 301015.SZ | Qingdao Baheal Medical INC. | $1.5B | 86 | STRONG BUY |
| AHG | Akso Health Group | $1.3B | 12 | STRONG SELL |
| 603368.SS | Guangxi LiuYao Group Co., Ltd | $854M | 92 | STRONG BUY |
| 600998.SS | Jointown Pharmaceutical Group Co., Ltd | $3.4B | 80 | BUY |
| 600332.SS | Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | $4.7B | 75 | BUY |
Peer medians: ROE 4.8% · P/E 26.5x · Gross margin 52.5%